NOS3 and metabolic dysfunction-associated steatotic liver disease: The endothelial nitric oxide synthase, nitric oxide and cyclic guanosine monophosphate (eNOS-NO-cGMP) signaling pathway has also been shown to affect the progression of NAFLD to NASH.